Autoimmune studies in narcolepsy

Narcolepsy and Hypersomnia

Volumn , Issue , 2006, Pages 451-458

  Silber, Michael H ^a   Black, John L ^a   Krahn, Lois E ^b   Fredrickson, Paul A ^c  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70249100713     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (30)

1. Juji T, Satake M, Honda Y, Doi Y. HLA antigens in Japanese patients with narcolepsy: all the patients were DR2 positive. Tissue Antigens 1984; 24:316-319.
2. Mignot E, Lin X, Arrigoni J, Macaubas C, Olive F, Hallmayer J, Underhill P, Guilleminault C, Dement WC, Grumet PC. DQB10602 and DQA10102 (DQ1) are better markers than DR2 for narcolepsy in caucasian and black Americans. Sleep 1994; 17:S60-S67.
3. Ellis MC, Hetisimer AH, Ruddy DA, Hansen SL, Kronmal GS, McClelland E, Quintana L, Drayna DT, Aldrich MS, Mignot E. HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy. Immunogenetics 1997; 46:410-417.
4. Mignot E. Genetic and familial aspects of narcolepsy. Neurology 1998; 50:S16-S22.
5. Silber MH, Krahn LE, Olson EJ, Pankratz VS. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population based study. Sleep 2002; 25:197-202.
6. Rubin RL, Hajdukovich RM, Mitler MM. HLA-DR2 association with excessive somnolence in narcolepsy does not generalize to sleep apnea and is not accompanied by systemic autoimmune abnormalities. Clin Immunol Immunopathol 1988; 49:149-158.
7. Black JL, Krahn LE, Pankratz VS, Silber MH. Search for neuronal-specific and non-neuronally-specific antibodies in the sera of patients with HLA DQB10602 positive and negative narcolepsy. Sleep 2002; 25:719-723.
8. Billiard M, Laaberki MF, Reygrobellet C, Seignalet J, Brissaud L, Besset A. Elevated antibodies to streptococcal antigens in narcoleptic subjects (abstr). Sleep Res 1989; 18:201.
9. Montplaisir J, Poirier G, Lapierre O, Montplaisir S. Streptococcal antigens in narcolepsy and idiopathic hypersomnia (abstr). Sleep Res 1989; 18:271.
10. Mueller-Eckhardt G, Meier-Ewart K, Schiefer HG. Is there an infectious origin of narcolepsy? Lancet 1990; 335:424.
11. Overeem S, Geleijns K, Garssen MPJ, Jacobs BC, van Doorn PA, Lammers GJ. Screening for antiganglioside antibodies in hypocretin-deficient human narcolepsy. Neurosci Lett 2003; 341:13-16.
12. Overeem S, Dalmau J, Bataller L, Nishino S, Mignpot E, Verschuuren J, Lammers GJ. Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology 2004; 62:138-140.
13. Fredrikson S, Carlander B, Billiard M, Link H. CSF immune variables in patients with narcolepsy. Acta Neurol Scand 1990; 81:253-254.
14. Smith AJ, Jackson MW, Neufing P, McEvoy RD, Gordon TP. A functional autoantibody in narcolepsy. Lancet 2004; 364:2076-2077.
15. Hinze-Selch D, Wetter TC, Zhang Y, Lu HC, Albert ED, Mullington J, Wekerle H, Holsboer F, Pollmacher T. In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls. Neurology 1998; 50:1149-1152.
16. Matsuki K, Juji T, Honda Y. Immunological features of narcolepsy in Japan. In: Honda Y, Juji T, eds. HLA in Narcolepsy. Berlin: Springer-Verlag, 1998:150-157.
17. Strohmaier P, Mueller-Eckhardt G, Meier-Ewart K. Cellular approach for detecting narcolepsy-specific alterations in DR2 haplotypes. Hum Immunol 1998; 22:221-225.
18. Okun M, Giese S, Lin L, Einen M, Mignot E, Coussons-Read ME. Exploring the cytokine and endocrine involvement in narcolepsy. Brain Behav Immun 2004; 18:326-332.
19. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997; 82:1313-1316.
20. Black JL 3rd, Silber MH, Krahn LE et al. Analysis of hypocretin (orexin) antibodies in patients with narcolepsy. Sleep 2005; 28:427-431.
21. Black JL 3rd, Silber MH, Krahn LE et al. Studies of humoral immunity to preprohypocretin in HLA DQB10602 positive narcoleptics with cataplexy. Biol Psychiatry 2005; 58:504-509.
22. Black JL 3rd, Avula RK, Walker DL et al. HLA DQB10602 positive narcoleptic subjects with cataplexy have CSF IgG reactive to rat hypothalamic protein extract (letter). Sleep 2005; 28:1191-1192.
23. Malik S, Boeve BF, Krahn LE, Silber MH. Narcolepsy associated with other central nervous system disorders. Neurology 2001; 57:539-541.
24. Aldrich MS, Naylor MW. Narcolepsy associated with lesions of the diencephalon. Neurology 1989; 39:1505-1508.
25. Gledhill RF, Bartel PR, Yoshida Y, Nishino S, Scammell TE. Narcolepsy caused by acute disseminated encephalomyelitis. Arch Neurol 2004; 61:758-760.
26. Kubota H, Kanbayashi T, Tanabe Y, Takanashi J, Kohno Y. A case of acute disseminated encephalomyelitis presenting hypersomnia with decreased hypocretin level in cerebrospinal fluid. J Child Neurol 2002; 17:537-539.
27. Autret A, Lucas B, Henry-Lebras F, de Toffol B. Symptomatic narcolepsies. Sleep 1994; 17:S21-S24.
28. Schrader H, Gotlibsen OB, Skomedal GN. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology 1980; 30:105-108.
29. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27:469-474.
30. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R. et al. Amutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brain. Nature Medicine 2000; 6:991-997.